ELSS Calculator
₹ 20,000 per month
1
Time period
6 months1 year3 year
Invested amount ₹ 3,30,00,000
Would have become
₹ 58,08,477
Tax Saving
Total Investment
Total Interest 
Mutual Fund Calculator
Monthly SIP Amount (₹)
Rate of Interest (% p.a.)
1
Time period (In years)
1
Total Invested 
Total Interest 
Total Amount after 5 years
1 Year Ret 0%
1Y
2Y
3Y
5Y
10Y
Fund Details
NAV
0
Sub-Type
Rating
Min. SIP Amount
0
Fund Age(Year)
124.48
Fund Size
0
Fund Performance
1 Month
0%
3 Month
0%
6 Month
0%
1 Year
0%
3 Year
0%
5 Year
0%
Mutual Fund Calculator
Monthly SIP Amount (₹)
Rate of Interest (% p.a.)
1
Time period (In years)
1
Total Invested 
Total Interest 
Total Amount after 5 years
Know This Fund
As on 25 May 2024
Investment strategy that balances risk & reward by dividing the investment portfolio among different types of asset classes.

Comparison with same funds

Equity, Flexi Cap funds
Ret 1M
Ret 1Y
Ret 3Y
Ret 5Y
No items to show...
Charges & Taxes Expense Ratio
Expense Ratio (Inclusive of GST): 0%
Exit load  0%
Stamp Duty  0%
Fund Management
The various expenses, charges and taxes associated with your Mutual Fund
Riskometer
Mutual Fund Investments are subject to market risk. Read all scheme related documents carefully.
AMC and Fund details
Rank (total sets)
0
Date of Incorporation
1900-01-01
Total AUM
1900-01-01

Latest News

Adani Ports Clinches Spot In Sensex, Trent In Sensex 50
💰Adani Ports has ousted IT behemoth Wipro to secure a coveted position in the 30 stock index. 💰BSE 100: REC, HDFC AMC, Canara Bank, Cummins India, and PNB will be included, replacing Page Industries, SBI Cards, ICICI Prudential Life Insurance, Jubil...
24 May 2024 | 10:00 PM

Multibagger stock: Voltamp Transformers climbs over 370% in just 16 months
Voltamp Transformers' shares have consistently maintained an upward trajectory, rising from ₹2,518 apiece in February 2023 to the current market price of ₹11,970, delivering a staggering return of nearly 375%. For long-term investors, the stock has b...
24 May 2024 | 09:42 PM

Glenmark Pharmaceuticals Q4 Results: Net loss widens to  ₹1,238.6 crore
Glenmark Pharmaceuticals announced its January-March quarter results for fiscal 2023-23 (Q4FY24) on Friday, reporting a net loss of ₹1,238.6 crore, compared to a loss of ₹549.4 crore in the corresponding period last year. The pharma major's revenue f...
24 May 2024 | 09:39 PM

No impact of elections on sales, expect robust FY25: Ashok Leyland
The ongoing general elections have had little impact on Ashok Leyland's sales, indicating a promising outlook for the company as well as the broader commercial vehicles (CV) segment for FY25. This is, however, contrary to market expectations of a slo...
24 May 2024 | 09:32 PM

Earn smarter returns with Real Estate Investment Trusts
REITs are an asset class that bridge the divide by bringing the opportunity to invest in high-end commercial real estate to retail investors. Simply put, in India, REITs own, operate, or finance income-generating real estate properties. As an investo...
24 May 2024 | 09:24 PM

Take your next step